319 related articles for article (PubMed ID: 25870276)
1. Inhibition of TLR2 signaling by small molecule inhibitors targeting a pocket within the TLR2 TIR domain.
Mistry P; Laird MH; Schwarz RS; Greene S; Dyson T; Snyder GA; Xiao TS; Chauhan J; Fletcher S; Toshchakov VY; MacKerell AD; Vogel SN
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5455-60. PubMed ID: 25870276
[TBL] [Abstract][Full Text] [Related]
2. Divergent roles of amino acid residues inside and outside the BB loop affect human Toll-like receptor (TLR)2/2, TLR2/1 and TLR2/6 responsiveness.
Qiu Y; Ding Y; Zou L; Tan Z; Liu T; Fu X; Xu W
PLoS One; 2013; 8(4):e61508. PubMed ID: 23626692
[TBL] [Abstract][Full Text] [Related]
3. The nitrone spin trap 5,5‑dimethyl‑1‑pyrroline N‑oxide binds to toll-like receptor-2-TIR-BB-loop domain and dampens downstream inflammatory signaling.
Muñoz MD; Gutierrez LJ; Delignat S; Russick J; Gomez Mejiba SE; Lacroix-Desmazes S; Enriz RD; Ramirez DC
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1152-1159. PubMed ID: 30684639
[TBL] [Abstract][Full Text] [Related]
4. Structural and functional evidence for the role of the TLR2 DD loop in TLR1/TLR2 heterodimerization and signaling.
Gautam JK; Ashish ; Comeau LD; Krueger JK; Smith MF
J Biol Chem; 2006 Oct; 281(40):30132-42. PubMed ID: 16893894
[TBL] [Abstract][Full Text] [Related]
5. R753Q polymorphism inhibits Toll-like receptor (TLR) 2 tyrosine phosphorylation, dimerization with TLR6, and recruitment of myeloid differentiation primary response protein 88.
Xiong Y; Song C; Snyder GA; Sundberg EJ; Medvedev AE
J Biol Chem; 2012 Nov; 287(45):38327-37. PubMed ID: 22992740
[TBL] [Abstract][Full Text] [Related]
6. Phloretin as a Potent Natural TLR2/1 Inhibitor Suppresses TLR2-Induced Inflammation.
Kim J; Durai P; Jeon D; Jung ID; Lee SJ; Park YM; Kim Y
Nutrients; 2018 Jul; 10(7):. PubMed ID: 29976865
[TBL] [Abstract][Full Text] [Related]
7. Insight into the sequence-structure relationship of TLR cytoplasm's Toll/Interleukin-1 receptor domain towards understanding the conserved functionality of TLR 2 heterodimer in mammals.
Ghosh SK; Saha B; Banerjee R
J Biomol Struct Dyn; 2021 Sep; 39(15):5348-5357. PubMed ID: 32643540
[TBL] [Abstract][Full Text] [Related]
8. A Decoy Peptide that Disrupts TIRAP Recruitment to TLRs Is Protective in a Murine Model of Influenza.
Piao W; Shirey KA; Ru LW; Lai W; Szmacinski H; Snyder GA; Sundberg EJ; Lakowicz JR; Vogel SN; Toshchakov VY
Cell Rep; 2015 Jun; 11(12):1941-52. PubMed ID: 26095366
[TBL] [Abstract][Full Text] [Related]
9. Differential adapter recruitment by TLR2 co-receptors.
Piao W; Ru LW; Toshchakov VY
Pathog Dis; 2016 Jul; 74(5):. PubMed ID: 27150837
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of the binding mode of Toll/interleukin-1 receptor (TIR) domain proteins during TLR2 signaling.
Nada M; Ohnishi H; Tochio H; Kato Z; Kimura T; Kubota K; Yamamoto T; Kamatari YO; Tsutsumi N; Shirakawa M; Kondo N
Mol Immunol; 2012 Oct; 52(3-4):108-16. PubMed ID: 22673208
[TBL] [Abstract][Full Text] [Related]
11. The novel small-molecule antagonist MMG-11 preferentially inhibits TLR2/1 signaling.
Grabowski M; Murgueitio MS; Bermudez M; Wolber G; Weindl G
Biochem Pharmacol; 2020 Jan; 171():113687. PubMed ID: 31678495
[TBL] [Abstract][Full Text] [Related]
12. SARM modulates MyD88-mediated TLR activation through BB-loop dependent TIR-TIR interactions.
Carlsson E; Ding JL; Byrne B
Biochim Biophys Acta; 2016 Feb; 1863(2):244-53. PubMed ID: 26592460
[TBL] [Abstract][Full Text] [Related]
13. Probing subtle conformational changes induced by phosphorylation and point mutations in the TIR domains of TLR2 and TLR3.
Mahita J; Sowdhamini R
Proteins; 2018 May; 86(5):524-535. PubMed ID: 29383749
[TBL] [Abstract][Full Text] [Related]
14. Investigating the effect of key mutations on the conformational dynamics of toll-like receptor dimers through molecular dynamics simulations and protein structure networks.
Mahita J; Sowdhamini R
Proteins; 2018 Apr; 86(4):475-490. PubMed ID: 29383743
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis identifies residues crucial for homodimerization of myeloid differentiation factor 88 (MyD88) and for its function in immune cells.
Loiarro M; Volpe E; Ruggiero V; Gallo G; Furlan R; Maiorino C; Battistini L; Sette C
J Biol Chem; 2013 Oct; 288(42):30210-30222. PubMed ID: 24019529
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of TLR4 signaling by TRAM-derived decoy peptides in vitro and in vivo.
Piao W; Vogel SN; Toshchakov VY
J Immunol; 2013 Mar; 190(5):2263-72. PubMed ID: 23345333
[TBL] [Abstract][Full Text] [Related]
17. In silico approach to inhibition of signaling pathways of Toll-like receptors 2 and 4 by ST2L.
Basith S; Manavalan B; Govindaraj RG; Choi S
PLoS One; 2011; 6(8):e23989. PubMed ID: 21897866
[TBL] [Abstract][Full Text] [Related]
18. Targeting Toll-like receptor (TLR) signaling by Toll/interleukin-1 receptor (TIR) domain-containing adapter protein/MyD88 adapter-like (TIRAP/Mal)-derived decoy peptides.
Couture LA; Piao W; Ru LW; Vogel SN; Toshchakov VY
J Biol Chem; 2012 Jul; 287(29):24641-8. PubMed ID: 22648407
[TBL] [Abstract][Full Text] [Related]
19. Differential involvement of BB loops of toll-IL-1 resistance (TIR) domain-containing adapter proteins in TLR4- versus TLR2-mediated signal transduction.
Toshchakov VU; Basu S; Fenton MJ; Vogel SN
J Immunol; 2005 Jul; 175(1):494-500. PubMed ID: 15972684
[TBL] [Abstract][Full Text] [Related]
20. Rational design of peptide derivatives for inhibition of MyD88-mediated toll-like receptor signaling in human peripheral blood mononuclear cells and epithelial cells exposed to Francisella tularensis.
Ryan DA; Degardin M; Alam S; Kissner TL; Hale M; Cameron MD; Rebek M; Ajami D; Saikh KU; Rebek J
Chem Biol Drug Des; 2017 Dec; 90(6):1190-1205. PubMed ID: 28599094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
